Rare diseases
Investigational molecules
Locations
Study of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors
FranceStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
BulgariaStudy of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients
BelgiumStudy of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer
BelgiumStudy on BI-1910 and Pembrolizumab for Patients with Advanced Solid Tumors
DenmarkStudy of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
CzechiaStudy of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment
CzechiaStudy Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer
BelgiumStudy on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer
BelgiumStudy of ALE.C04 and Pembrolizumab for Adults with Recurrent or Metastatic Head and Neck Cancer
FranceStudy on the Safety and Effectiveness of Pembrolizumab, Vibostolimab, and Lenvatinib for Patients with PD-1 Refractory Melanoma
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
